Trial Profile
A Study To Evaluate The Efficacy and Safety of Sofosbuvir Based New Regimens With Ribavirin, Daclatasvir or Simeprevir In Difficult To Treat Chronic Hepatitis C Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Aug 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Daclatasvir; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2015 New trial record